Suppr超能文献

全球神经障碍负担:将证据转化为政策。

The global burden of neurological disorders: translating evidence into policy.

机构信息

National Institute for Stroke and Applied Neurosciences, Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand.

Institute for Health Metrics Evaluation, University of Washington, Seattle, WA, USA.

出版信息

Lancet Neurol. 2020 Mar;19(3):255-265. doi: 10.1016/S1474-4422(19)30411-9. Epub 2019 Dec 5.

Abstract

Neurological disorders are the leading cause of disability and the second leading cause of death worldwide. In the past 30 years, the absolute numbers of deaths and people with disabilities owing to neurological diseases have risen substantially, particularly in low-income and middle-income countries, and further increases are expected globally as a result of population growth and ageing. This rise in absolute numbers of people affected suggests that advances in prevention and management of major neurological disorders are not sufficiently effective to counter global demographic changes. Urgent measures to reduce this burden are therefore needed. Because resources for health care and research are already overstretched, priorities need to be set to guide policy makers, governments, and funding organisations to develop and implement action plans for prevention, health care, and research to tackle the growing challenge of neurological disorders.

摘要

神经紊乱是全世界导致残疾和死亡的首要原因。在过去 30 年中,因神经疾病而死亡和残疾的绝对人数大幅上升,特别是在低收入和中等收入国家,而且由于人口增长和老龄化,预计全球还会进一步上升。受影响人数的绝对增加表明,预防和管理主要神经紊乱方面的进展还不足以有效应对全球人口结构变化。因此,需要采取紧急措施来减轻这一负担。由于医疗保健和研究资源已经捉襟见肘,需要确定优先事项,以指导决策者、政府和资助组织制定和实施预防、医疗保健和研究行动计划,以应对神经紊乱日益增长的挑战。

相似文献

1
The global burden of neurological disorders: translating evidence into policy.
Lancet Neurol. 2020 Mar;19(3):255-265. doi: 10.1016/S1474-4422(19)30411-9. Epub 2019 Dec 5.
3
The burden of neurological diseases in Europe: an analysis for the Global Burden of Disease Study 2017.
Lancet Public Health. 2020 Oct;5(10):e551-e567. doi: 10.1016/S2468-2667(20)30190-0.
5
Burden of Neurological Disorders Across the US From 1990-2017: A Global Burden of Disease Study.
JAMA Neurol. 2021 Feb 1;78(2):165-176. doi: 10.1001/jamaneurol.2020.4152.
8
The global burden of mental, neurological and substance use disorders: an analysis from the Global Burden of Disease Study 2010.
PLoS One. 2015 Feb 6;10(2):e0116820. doi: 10.1371/journal.pone.0116820. eCollection 2015.
9
Health in times of uncertainty in the eastern Mediterranean region, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Lancet Glob Health. 2016 Oct;4(10):e704-13. doi: 10.1016/S2214-109X(16)30168-1. Epub 2016 Aug 25.

引用本文的文献

1
Mesenchymal stem cell-derived extracellular vesicles: current advances in preparation and therapeutic applications for neurological disorders.
Front Cell Dev Biol. 2025 Aug 18;13:1626996. doi: 10.3389/fcell.2025.1626996. eCollection 2025.
2
Neuronal differentiation of human dental pulp stem cells induced by co-treatment of ergothioneine.
PLoS One. 2025 Sep 2;20(9):e0331120. doi: 10.1371/journal.pone.0331120. eCollection 2025.
5
The Role of the human microbiome in neurodegenerative diseases: A Perspective.
Curr Genet. 2025 Aug 21;71(1):17. doi: 10.1007/s00294-025-01319-8.
7
: How and Why It Became a Model Organism.
Int J Mol Sci. 2025 Aug 2;26(15):7485. doi: 10.3390/ijms26157485.
10
Harnessing nanotechnology for stem-cell therapies: revolutionizing neurodegenerative disorder treatments - a state-of-the-art update.
Front Pharmacol. 2025 Jul 23;16:1630475. doi: 10.3389/fphar.2025.1630475. eCollection 2025.

本文引用的文献

1
Action Plan for Stroke in Europe 2018-2030.
Eur Stroke J. 2018 Dec;3(4):309-336. doi: 10.1177/2396987318808719. Epub 2018 Oct 29.
2
Priorities to reduce the burden of stroke in Latin American countries.
Lancet Neurol. 2019 Jul;18(7):674-683. doi: 10.1016/S1474-4422(19)30068-7. Epub 2019 Apr 24.
5
Global, regional, and national burden of stroke, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
Lancet Neurol. 2019 May;18(5):439-458. doi: 10.1016/S1474-4422(19)30034-1. Epub 2019 Mar 11.
6
The Emerging Evidence of the Parkinson Pandemic.
J Parkinsons Dis. 2018;8(s1):S3-S8. doi: 10.3233/JPD-181474.
7
Mobile Technology for Primary Stroke Prevention: A Proof-of-Concept Pilot Randomized Controlled Trial.
Stroke. 2019 Jan;50(1):196-198. doi: 10.1161/STROKEAHA.118.023058. Epub 2018 Nov 21.
8
Global, Regional, and Country-Specific Lifetime Risks of Stroke, 1990 and 2016.
N Engl J Med. 2018 Dec 20;379(25):2429-2437. doi: 10.1056/NEJMoa1804492.
9
Stroke research in 2018: extended time windows, refined benefit, and lifestyle prevention targets.
Lancet Neurol. 2019 Jan;18(1):2-3. doi: 10.1016/S1474-4422(18)30457-5.
10
The data to put neurology on top of the public-health agenda.
Lancet Neurol. 2019 Jan;18(1):1. doi: 10.1016/S1474-4422(18)30439-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验